References
Anderson LV, Harrison RM, Pogue R et al (2000) Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord 10:553–559
Bolduc V, Marlow G, Boycott KM et al (2010) Recessive mutations in the putative calcium-activated chloride channel anoctamine 5 cause proximal LGMDL and distal MMD3 muscular dystrophies. Am J Hum Genet 86:213–221
Confalonieri P, Oliva L, Andreetta F et al (2003) Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J Neuroimmunol 142:130–136
Deschauer M, Joshi PR, Gläser D, Hanisch F, Stoltenburg G, Zierz S (2011) Muscular dystrophy due to mutations in anoctamin 5: clinical and molecular genetic findings. Nervenarzt 82:1596–1603
Duran C, Hartzell HC (2011) Physiological roles and diseases of Tmem16/anoctamin proteins: are they all chloride channels? Acta Pharmacol Sin 32:685–692
Gallardo E, Rojas-Garcia R, de Luna N, Pou A, Brown RH Jr, Illa I (2001) Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 57:2136–2138
Hicks D, Sarkozy A, Muelas N et al (2011) A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy. Brain 134:171–182
Jaiswal JK, Marlow G, Summerill G et al (2007) Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect. Traffic 8:77–88
Jarry J, Rioux MF, Bolduc V, Robitaille Y, Khoury V, Thiffault I, Tétreault M, Loisel L, Bouchard JP, Brais B (2007) A novel autosomal recessive limb-girdle muscular dystrophy with quadriceps atrophy maps to 11p13-p12. Brain 130:368–380
Mahjneh I, Jaiswal J, Lamminen A, Somer M, Marlow G, Kiuru-Enari S, Bashir R (2010) A new distal myopathy with mutation in anoctamin 5. Neuromuscul Disord 20:791–795
Mc Nally EM, Ly CT, Rosenmann H et al (2000) Splicing mutations in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Genet 91:305–312
Milone M, Liewluk T, Winder TL, Pianosi PT (2012) Amyloidosis and exercise intolerance in ANO5 muscular dystrophy. Neuromuscul Disord 22:13–15
Nguyen K, Bassez G, Krahn M et al (2007) Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol 64:1176–1182
Rosales XQ, Gastier-Foster JM, Lewis S et al (2010) Novel diagnostic features of dysferlinopathies. Muscle Nerve 42:14–21
Rowin J, Meriggioli MN, Cochran EJ, Sanders DB (1999) Prominent inflammatory changes on muscle biopsy in patients with Miyoshi myopathy. Neuromuscul Disord 9:417–420
Sakuma H, Niiyama S, Amoh Y, Katsuoka K (2011) Chlamydophila pneumoniae infection induced nodular vasculitis. Case Rep Dermatol 3:263–267
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pénisson-Besnier, I., Saint-André, JP., Hicks, D. et al. Myopathy caused by anoctamin 5 mutations and necrotizing vasculitis. J Neurol 259, 1988–1990 (2012). https://doi.org/10.1007/s00415-012-6502-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-012-6502-x